Truhlsen Eye Institute at the University of Nebraska Medical Center in Omaha has begun using new laser technology to treat eye diseases, according to a Health Canal report.
The Supra Scan Multi-Spot Laser, which has a yellow light, was recently used to treat a patient with proliferative diabetic retinopathy. Only one other laser of its kind is being used in the world, according to Quan Dong Nguyen, MD, the McGaw Memorial Endowed Chair in Ophthalmology and the director of the Truhlsen Eye Institute.
Diana Do, MD, director of the Carl Camras Center for Innovative Clinical Research at the institute, performed the first procedure.
The laser allows for more nuanced, problem-specific targeting. It may be more effective, efficient and safer than traditional lasers.
More Articles on Ophthalmology:
Cataract Surgery Laser Market to be Worth $2.4B by 2019
Pediatric Patients Could Benefit From Femtosecond Laser Cataract Surgery
Trillium Health Partner's Dr. Ike Ahmed Performed First Complex Cataract Surgery in Canada With 3D Guidance System